Biolinerx ltd. (BLRX)
Income statement / TTM
Jun'18Jun'17
RESEARCH AND DEVELOPMENT EXPENSES

0

0

SALES AND MARKETING EXPENSES

0

0

GENERAL AND ADMINISTRATIVE EXPENSES

0

0

OPERATING LOSS

0

0

NON-OPERATING INCOME (EXPENSES), NET

0

0

FINANCIAL INCOME

0

0

FINANCIAL EXPENSES

0

0

NET LOSS AND COMPREHENSIVE LOSS

0

0

LOSS PER ORDINARY SHARE - BASIC AND DILUTED

-0.05

-0.05

WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF LOSS PER ORDINARY SHARE

106,630

94,487